Lilly partners with Entos to develop therapies for neurologic diseases
The collaboration will use Entos’ Fusogenix nucleic acid delivery technology and Lilly's therapeutic cargo to develop nucleic acid…
AstraZeneca teams up with Ionis to develop and market eplontersen
30 Dec 21Eplontersen is an investigational ligand-conjugated antisense (LICA) medicine, designed to treat all types of TTR amyloidosis (ATTR)
Novavax extends manufacturing agreement with South Korea’s SK bioscience
24 Dec 21Under the expanded agreement, SK bioscience will reserve additional manufacturing capacity to produce antigen, a key component of…
Novartis teams up with BeiGene for TIGIT inhibitor ociperlimab
21 Dec 21With the latest partnership, the Swiss drugmaker intends to expand its capabilities in the research and development of…
Lilly teams up with Regor to develop drugs for metabolic disorders
13 Dec 21Lilly will make an upfront payment of up to $50m to Regor, in addition to potential milestone payments…
Merck partners with Thermo Fisher to manufacture molnupiravir in Canada
07 Dec 21Thermo Fisher will dedicate its manufacturing facility in Ontario, Canada to make Merck’s molnupiravir and distribute the drug…
Gilead selects AWS for development and delivery of new drugs
30 Nov 21The collaboration will support Gilead’s data-driven decision making, from biomarker discovery to manufacturing and clinical trials, and help…
Enzychem to manufacture Zydus Cadila’s ZyCoV-D in South Korea
29 Nov 21The partnership is expected to result in the manufacturing of an estimated 80 million doses of the plasmid…
GSK signs licensing deal with Arrowhead for NASH therapy
23 Nov 21Arrowhead will receive $120m in upfront payment for the Phase 1/2 NASH programme, along with potential milestone payments…
US to buy 10 million courses of Pfizer’s oral Covid-19 drug Paxlovid for $5.3bn
19 Nov 21Under the agreement, Pfizer will supply 10 million courses of the investigational Covid-19 drug to the US government,…